Pulmonary Salivary Gland Tumor, Mucoepidermoid Carcinoma: A Literature Review
文献类型：期刊论文
| 作者 | Hu, Shumin1,2,3,5; Gong, Jiali1,2,3,5; Zhu, Xiu1,4; Lu, Hongyang1,2,3,5 |
| 刊名 | JOURNAL OF ONCOLOGY
 |
| 出版日期 | 2022-11-02 |
| 卷号 | 2022 |
| ISSN号 | 1687-8450 |
| DOI | 10.1155/2022/9742091 |
| 通讯作者 | Lu, Hongyang(luhy@zjcc.org.cn) |
| 英文摘要 | Pulmonary mucoepidermoid carcinoma (PMEC) is the most common malignant salivary gland tumor in the lungs and accounts for 0.1-0.2% of all lung malignancies in adults. It has no specific epidemiological or clinical characteristics. Correct diagnosis requires the combined examinations of images, laboratories, pathology, and immunohistochemistry (IHC) as well as molecular characteristics. PMEC tumors are characterized by squamous, intermediate, and mucus-secreting cells. Currently, histological appearance, mitotic frequency, cellular atypia, and necrocytosis allow the classification of PMEC into low grade or high grade. Molecular changes are crucial to pathological diagnosis. The driver of PMEC seems to be the fusion protein MECT1-MAML2 that is generated from a genetic mutation in t (11; 19) (q21; p13), while other gene mutations are also reported. However, no treatment of PMEC exists so far; surgical excision is still the primary treatment, while the efficacies of chemotherapy or radiotherapy are undefined. Tyrosine kinase inhibitor (TKI) therapy and immunotherapy showed to have significant therapeutic effects but require more investigation and better understanding. This review focuses on the clinical characteristics, imaging and pathologic features, immunohistochemical examination, mutation analysis, differential diagnosis, prognosis, and treatment of PMEC. |
| WOS关键词 | PROGRAMMED DEATH LIGAND-1 ; GROWTH-FACTOR RECEPTOR ; DIFFERENTIAL-DIAGNOSIS ; CELL CARCINOMA ; FREE SURVIVAL ; LUNG-CANCER ; FEATURES ; EGFR ; EXPRESSION ; OUTCOMES |
| 资助项目 | Wu Jieping Medical Foundation ; [320.6750.2021-01-50] |
| WOS研究方向 | Oncology |
| 语种 | 英语 |
| WOS记录号 | WOS:000885044500003 |
| 出版者 | HINDAWI LTD |
| 资助机构 | Wu Jieping Medical Foundation |
| 源URL | [http://ir.hfcas.ac.cn:8080/handle/334002/130423]  |
| 专题 | 中国科学院合肥物质科学研究院 |
| 通讯作者 | Lu, Hongyang |
| 作者单位 | 1.Chinese Acad Sci, Inst Basic Med & Canc IBMC, Beijing 310022, Peoples R China 2.Univ Chinese Acad Sci, Zhejiang Canc Hosp, Zhejiang Key Lab Diag & Treatment Technol Torac On, Canc Hosp, Hangzhou 310022, Peoples R China 3.Univ Chinese Acad Sci, Zhejiang Canc Hosp, Canc Hosp, Dept Torac Med Oncol, Zhejiang 310022, Peoples R China 4.Univ Chinese Acad Sci, Zhejiang Canc Hosp, Canc Hosp, Dept Pathol, Zhejiang 310022, Peoples R China 5.Zhejiang Chinese Med Univ, Clin Med Coll 2, Hangzhou 310053, Peoples R China |
| 推荐引用方式 GB/T 7714 | Hu, Shumin,Gong, Jiali,Zhu, Xiu,et al. Pulmonary Salivary Gland Tumor, Mucoepidermoid Carcinoma: A Literature Review[J]. JOURNAL OF ONCOLOGY,2022,2022. |
| APA | Hu, Shumin,Gong, Jiali,Zhu, Xiu,&Lu, Hongyang.(2022).Pulmonary Salivary Gland Tumor, Mucoepidermoid Carcinoma: A Literature Review.JOURNAL OF ONCOLOGY,2022. |
| MLA | Hu, Shumin,et al."Pulmonary Salivary Gland Tumor, Mucoepidermoid Carcinoma: A Literature Review".JOURNAL OF ONCOLOGY 2022(2022). |
入库方式： OAI收割
来源：合肥物质科学研究院
浏览0
下载0
收藏0
其他版本
除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。